ArticleTheranostics2026

The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs.

Hong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.